Internal Medicine · San Leandro, CA
NPI
1154448587
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2500 Merced Street
San Leandro, CA, 94577
Phone (510) 454-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$139K
10,240 services
Medicare patients, 2024
14
Average age 70
Drug cost, 2024
$9.4M
2,961 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Derek W Shek prescribed most often to Medicare patients was Prednisone, with 555 prescriptions and refills. In total Derek W Shek wrote 2,961 Medicare prescriptions that cost $9.4M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Prednisone Generic | 555 | 653 | 106 | $3,994 |
| Abiraterone Acetate Generic | 531 | 568 | 78 | $83K |
| Tagrisso Osimertinib Mesylate | 198 | 198 | 23 | $3.4M |
| Dexamethasone Generic | 167 | 170 | 56 | $1,774 |
| Xtandi Enzalutamide | 96 | 96 | 18 | $1.1M |
| Olanzapine Generic | 86 | 92 | 50 | $610 |
| Anastrozole Generic | 76 | 212 | 26 | $2,714 |
| Ondansetron Odt Ondansetron | 67 | 67 | 37 | $751 |
| Ondansetron Hcl Generic | 60 | 62 | 37 | $497 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 57 | 57 | 35 | $2,887 |
| Potassium Chloride Generic | 42 | 126 | 23 | $1,514 |
| Hydroxyurea Generic | 39 | 121 | 13 | $2,142 |
| Prochlorperazine Maleate Generic | 38 | 38 | 22 | $514 |
| Brukinsa Zanubrutinib | 32 | 32 | Under 11 | $421K |
| Famotidine Generic | 32 | 45 | 23 | $263 |
Brand drugs: - claims; generic drugs: 2,312 claims; opioid claims: 130.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Derek W Shek were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.